Ethical approval
This study adhered to the Declaration of Helsinki. The patient provided a signed informed consent form and approved of the study to be published. Tocilizumab was used for FMF as off-label use. This report was approved by the local research ethics board.
Conflict of interest
None.
Funding
This study was funded by the Okinaka Memorial Institute of Medical Research.